SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 115 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is 0.10 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $4,169,000 | +226.0% | 219,415 | +181.3% | 0.69% | +203.1% |
Q4 2017 | $1,279,000 | -60.0% | 77,999 | -63.4% | 0.23% | -46.1% |
Q3 2017 | $3,195,000 | +225.7% | 213,027 | +91.1% | 0.42% | +162.3% |
Q2 2017 | $981,000 | +14.1% | 111,486 | +18.4% | 0.16% | +44.6% |
Q4 2015 | $860,000 | -8.0% | 94,183 | +53.8% | 0.11% | -36.7% |
Q2 2014 | $935,000 | -34.5% | 61,248 | -22.4% | 0.18% | -31.1% |
Q1 2014 | $1,427,000 | +2.8% | 78,938 | -21.0% | 0.26% | +3.6% |
Q4 2013 | $1,388,000 | – | 99,893 | – | 0.25% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Golden State Equity Partners | 154,360 | $897,000 | 0.45% |
Rhenman & Partners Asset Management AB | 761,429 | $4,424,000 | 0.44% |
Lombard Odier Asset Management (Switzerland) SA | 860,702 | $5,001,000 | 0.39% |
WASATCH ADVISORS LP | 10,576,997 | $61,452,000 | 0.30% |
Rokos Capital Management LLP | 977,663 | $5,861,000 | 0.27% |
KLK CAPITAL MANAGEMENT LLC | 44,323 | $258,000 | 0.26% |
Long Focus Capital Management, LLC | 340,000 | $1,975,000 | 0.25% |
Vanguard Capital Wealth Advisors | 33,380 | $193,000 | 0.14% |
Fort Sheridan Advisors LLC | 73,978 | $430,000 | 0.13% |
Delphia (USA) Inc. | 20,983 | $122,000 | 0.09% |